A Decision Support Tool for Appropriate Glucose-Lowering Therapy in Patients with Type 2 Diabetes-Reference-Cited by-同舟云学术

A Decision Support Tool for Appropriate Glucose-Lowering Therapy in Patients with Type 2 Diabetes

Published:2015-03 Issue:3 Volume:17 Page:194-202
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Ampudia-Blasco F. Javier¹,Benhamou Pierre Yves²,Charpentier Guillaume³,Consoli Agostino⁴,Diamant Michaela⁵,Gallwitz Baptist⁶,Khunti Kamlesh⁷,Mathieu Chantal⁸,Ridderstråle Martin⁹,Seufert Jochen¹⁰,Tack Cees¹¹,Vilsbøll Tina¹²,Phan Tra-Mi¹³,Stoevelaar Herman¹⁴

Affiliation:

1. Department of Medicine, University of Valencia, Valencia, Spain.

2. Department of Endocrinology & Diabetes, University Hospital, Grenoble, France.

3. Department of Medicine, Sud-Francilien Hospital, Corbeil-Essonnes, France.

4. Department of Medicine, University of Chieti, Chieti, Italy.

5. Department of Endocrinology & Diabetes, VU University Medical Center, Amsterdam, The Netherlands.

6. Department of Medicine IV, Eberhard-Karls-University, Tübingen, Germany.

7. Department of Medicine, University of Leicester, Leicester, United Kingdom.

8. Department of Medicine, University Hospital of Leuven, Leuven, Belgium.

9. Steno Diabetes Center, Gentofte, Denmark.

10. Division of Endocrinology & Diabetology, Department of Medicine II, University Hospital of Freiburg, Freiburg, Germany.

11. Department of Medicine, Radboud University Nijmegen, Nijmegen, The Netherlands.

12. Center for Diabetes Research, Department of Medicine, Gentofte Hospital, University of Copenhagen, Gentofte, Denmark.

13. Medical Affairs Europe, Novo Nordisk Health Care AG, Zürich, Switzerland.

14. Centre for Decision Analysis & Support, Ismar Healthcare, Lier, Belgium.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2014.0260

Reference29 articles.

1. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2. Intensive glucose control and macrovascular outcomes in type 2 diabetes

3. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

4. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

5. Factors associated with clinical inertia: an integrative review

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of a Digital Clinical Decision–Support System in General Practitioners’ Management of COPD in Norway;International Journal of Chronic Obstructive Pulmonary Disease;2021-08

2. Guiding Glucose Management Discussions Among Adults With Type 2 Diabetes in General Practice: Development and Pretesting of a Clinical Decision Support Tool Prototype Embedded in an Electronic Medical Record;JMIR Formative Research;2020-09-02

3. Potentially inappropriate prescribing for adults with diabetes mellitus: a scoping review protocol;JBI Evidence Synthesis;2020-02-14

4. Guiding Glucose Management Discussions Among Adults With Type 2 Diabetes in General Practice: Development and Pretesting of a Clinical Decision Support Tool Prototype Embedded in an Electronic Medical Record (Preprint);2020-02-10

5. Efficacy and Safety of Switching Patients Inadequately Controlled on Basal Insulin to Insulin Glargine 300 U/mL: The TRANSITION 2 Study;Diabetes Therapy;2019-11-28